Yuqi Wang

机构：Shanghai International Studies University, Harbin Medical University, China Pharmaceutical University, Xiamen University, Peking University, Harbin Institute of Technology, Sichuan University, West China Hospital of Sichuan University, Peking University People's Hospital, Second Affiliated Hospital of Harbin Medical University, Universiti Teknologi MARA · ORCID：0000-0003-0240-9048

发表论文 82 篇 · 总被引 367 次 · h-index 10

代表论文

• Current status and trends of nuclear energy under carbon neutrality conditions in China (2024 · Energy · 被引 70)
• Small-molecule targeting PKM2 provides a molecular basis of lactylation-dependent fibroblast-like synoviocytes proliferation inhibition against rheumatoid arthritis (2024 · European Journal of Pharmacology · 被引 42)
• Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets (2025 · MedComm · 被引 24)
• Federated Machine Learning Enables Risk Management and Privacy Protection in Water Quality (2025 · Environmental Science & Technology · 被引 14)
• Corydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2 (2025 · Journal of Ethnopharmacology · 被引 10)
• Identification of Key Post‐modification Enzymes Involved in the Biosynthesis of Lanostane‐type Triterpenoids in the Medicinal Mushroom Antrodia camphorata. (2024 · Angewandte Chemie International Edition · 被引 6)